Caplin Point Laboratories features in Forbes Asia’s ‘200 Best Under a Billion’ list

03 Jul 2015 Evaluate

Caplin Point Laboratories has been selected under Forbes Asia’s 200 Best Under a Billion list for 2015, for the second consecutive year. The list has been published in the magazine’s July 2015 edition.

Forbes Asia has selected 200 best performing companies, with revenues of less than a billion, from a list of 17,000 public listed companies across the Asia-Pacific. A total of 11 companies have been selected from India, out of which Caplin Point is the only pharmaceutical company to feature on the list in both 2014 and 2015.

Caplin Point Laboratories is a niche pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa.



Caplin Point Lab Share Price

1964.95 -5.95 (-0.30%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...